Evidence map›Paper›PMID 12460122›Full record

ArticleThe Biochemical journal2003

Distance of sequons to the C-terminus influences the cellular N-glycosylation of the prion protein.

Adrian R Walmsley, Nigel M Hooper

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. N-linked protein glycosylation in the endoplasmic reticulum.Cold Spring Harbor perspectives in biology · 2013
    Review
  3. Article
  4. Article
  5. Article
  6. Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adrian R WalmsleySchool of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, U.K.
Nigel M Hooper
University of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-specific differences in the utilization of the two N-glycosylation sequons (Asn180-Ile-Thr and Asn196-Phe-Thr) of the prion protein (PrP) have been proposed to influence the aetiology of the neurodegenerative prion diseases. As the N-glycosylation of PrP is ablated by deletion of the C-terminal glycosyl-phosphatidylinositol (GPI) anchor signal sequence, we have investigated the determinants for PrP sequon utilization in human neuronal cells using the novel approach of restoring N-glycosylation to secreted forms of PrP lacking a GPI anchor. N-glycosylation was restored to an efficiency comparable with that of GPI anchored PrP when the distance of the sequon to the C-terminus was increased so that it was sufficient to reach the active site of oligosaccharyltransferase before chain termination. Our findings indicate that sequon utilization in PrP is a co-translational process that precedes GPI anchor addition and, as such, will be greatly influenced by the dynamics of the translocon-oligosaccharyltransferase complex.

Indexed as

AmidohydrolasesAnimalsBase SequenceBlotting, WesternDNA PrimersElectrophoresis, Polyacrylamide GelGlycosylationHumansHydrolysisMicePeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePhosphatidylinositol Diacylglycerol-LyasePrionsTumor Cells, CulturedType C PhospholipasesAmidohydrolasesDNA PrimersPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePhosphatidylinositol Diacylglycerol-LyasePrionsType C Phospholipases

Identifiers

PMID12460122
PMCPMC1223167
OpenAlexW2079576608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.